PSC
MDXG icon

Piper Sandler & Co’s MiMedx Group MDXG Stock Holding History

Piper Sandler & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-18,000
Closed -$128K – 154
2014
Q2 		$128K Buy
+18,000
New +$105K 0.09% 81

Other funds holding MDXG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Piper Sandler & Co's MDXG Position: Q3 2014 in Review

Piper Sandler & Co sold out of MiMedx Group (MDXG) in Q3 2014, closing a stake of 18,000 shares — an estimated $128K sold.

Piper Sandler & Co first reported a position in MDXG in Q2 2014 and held it in 1 quarter. The position peaked at $128K in Q2 2014. 125 funds tracked by Wall St. Rank hold MDXG as of Q3 2014.

  • Piper Sandler & Co reported no remaining MiMedx Group position as of Q3 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 18,000 MiMedx Group shares in Q3 2014, an estimated $128K.
  • Piper Sandler & Co first reported a position in MiMedx Group in Q2 2014 and held it in 1 quarter.
  • Piper Sandler & Co's MiMedx Group position peaked at $128K in Q2 2014.
  • 125 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2014.

Based on Piper Sandler & Co's 13F filing for Q3 2014, filed 14 Nov 2014.